期刊文献+

肥大细胞在糖尿病肾病患者肾组织中的分布及相关性研究 被引量:7

Distribution of renal mast cells in and their association with diabetic nephropathy
在线阅读 下载PDF
导出
摘要 目的糖尿病肾病(diabetic nephropathy,DN)是慢性炎症性疾病。肥大细胞是多功能的免疫细胞,具有以多种方式参与DN发生发展的潜在能力。但目前尚未见有较全面的对肥大细胞与DN关系的分析和研究报道。文中研究在DN发生发展过程中肾组织中肥大细胞数量、活化水平的变化,及探讨肥大细胞与DN发生发展的相关性及可能病理作用。方法选取DN病例80例,其中早期19例、中期32例,晚期29例。同时选取正常供肾16例作为正常对照。以类胰蛋白酶作为肥大细胞标记分子,利用免疫组化的方法分析肾穿刺组织标本中肥大细胞的数量。以CD3、CD20、CD68分别作为肾组织T淋巴细胞、B淋巴细胞和巨噬细胞的标记分子,利用免疫组化染色方法分析肾穿刺组织标本中上述炎症细胞数量。根据肥大细胞周围的甲苯胺蓝异染颗粒及细胞内颗粒减少情况分析肥大细胞的脱颗粒反应,据以分析肾织织肥大细胞的活化水平。以此为基础分析肾组织中肥大细胞与DN临床病理指标的相关性。结果①在正常对照和DN患者的肾组织中肥大细胞主要分布于肾小管间质,肾小球中极少发现肥大细胞。DN患者的肾组织中,还可见肥大细胞侵入肾小管壁。②正常对照肾组织肥大细胞数量很少。在DN的肾组织中,肥大细胞数量随着病情发展而显著增加。③与正常对照相比,DN患者肾组织肥大细胞发生脱颗粒的比例显著增高,且表现为随DN进展而逐渐增加的趋势。④相关性分析显示,DN患者肾组织肥大细胞数量与肾功能损伤指标、小管间质损伤指标和炎症指标具有显著相关性。结论肥大细胞参与DN的发生发展过程,可能主要通过脱颗粒作用,释放细胞内的生物活性物质。肥大细胞在DN的肾小管间质损伤中发挥重要作用。肥大细胞可望成为DN防治的新靶标。 Objective This study was to observe the changes in the number and degranulation level of mast cells in the renal tissue of patients with diabetic nephropathy (DN) during the development of the disease and to explore the pathogenic role of mast cells. Methods We recruited in this study 80 patients at different clinical stages of DN and 16 normal kidney donors. We performed immunohistochemical staining for tryptase, CD3, CD20 and CD68, and toluidine blue staining on the renal sections of the patients and controls for examination of the changes in the number and degranulation level of mast cells. Then we analyzed the correlation between mast cells and the clinical and pathological indexes of the patients. Results Renal mast cells were found distributed mainly in the tubular interstitium in both normal controls and patients, few in the glomeruli, and occasionally infiltrated in the wall of the atrophy tu- bulus. Only a few renal mast cells were observed in the normal control group, but their number was increased with the development of DN. And the degranulation rate of mast cells, too, was increased with the development of DN, as compared with that in the normal controls. The increased number and degrannlation level of mast cells were significantly correlated with renal function injury, tubular interstitial injury and tubular interstitial inflammation indexes. Conclusion Mast cells are involved in the development of diabetic nephropathy, mainly through releasing bioactive substances into tubular interstitium by degranulation. Mast cells play an important role inrenal tubular interstitial injury and promise to be a new target in the prevention and treatment of diabetic nephropathy.
出处 《医学研究生学报》 CAS 北大核心 2012年第6期622-627,共6页 Journal of Medical Postgraduates
关键词 肥大细胞 糖尿病肾病 病理作用 类胰蛋白酶 脱颗粒 Mast cell Diabetic nephropathy Pathogenic role Tryptase Degranulation
  • 相关文献

参考文献19

  • 1Balakumar P, Arora MK, Ganti SS, et al. Recent advances in pharmacotherapy for diabetic nephropathy: current perspectivesand future directions [ J ]. Pharmacol Res, 2009, 60 ( 1 ) : 24- 32.
  • 2Rtlger BM, Hasan Q, Greenhill NS, et al. Mast ceils and type VIII collagen in human diabetic nephropathy [ J ]. Diabetologia, 1996, 39(6) : 1215-1222.
  • 3Roberts IS, Brenchley PE. Mast cells : the forgotten cells of renal fibrosis[J]. J Clin Pathol, 2000, 53 ( 11 ) : 858-862.
  • 4OkofiK, Stachura J. Increased mast cell density in renal interstiti- um is correlated with relative interstitial volume, serum creatinine and urea especially in diabetic nephropathy but also in primary glomerulonephritis [ J ]. Pol J Pathol, 2007, 58 (3) : 193-197.
  • 5Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classifi- cation of diabetic nephropathy[J]. J Am Soc Nephrol, 2010, 21 (4) : 556-563.
  • 6Okon K, Szumera A, Kuzniewski M. Are CD34 + cells found in renal interstitial fibrosis? [J] Am J Nephrol, 2003, 23 ( 6 ) : 409-414.
  • 7Singh LK, Boucher W, Pang X, et al. Potent mast cell degranu- lation and vascular permeability triggered by urocortin through ac- tivation of corticotropin-releasing hormone receptors [ J ]. J Phar- macol Exp Ther, 1999, 288(3) :1349-1156.
  • 8Kawakami T. A crucial door to the mast cell mystery knocked in [J]. J Immunol, 2009, 183(11) : 6863-6881.
  • 9Galli S J, Kalesnikoff J, Grimbaldeston MA, et al. Mast cells as “tunable” effector and immunoregulatory cells: recent advances [J]. Annu Rev Immunol, 2005, 23: 749-786.
  • 10Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence[J]. Curr Opin Immunol, 2007, 19 ( 1 ) : 31-38.

二级参考文献50

  • 1郭志福,何韶衡,李强.蛋白酶激活受体-2介导的呼吸道上皮细胞活化在哮喘中的作用[J].医学研究生学报,2004,17(10):929-931. 被引量:2
  • 2何梦璋,梁剑辉,徐军.竞争性逆转录-聚合酶链反应对哮喘患者诱导痰白细胞介素-10基因表达的定量分析[J].医学研究生学报,2007,20(1):49-52. 被引量:1
  • 3Metz M,Maurer M.Mast cells-key effector cells in immune responses[J].Trends Immunol,2007,28(5):234-241.
  • 4Galli SJ,Grimbaldeston M,Tsai M.Immunomodulatory mast cells:Negative,as well as positive,regulators of immunity[J].Nat Rev Immunol,2008,8(6):478-486.
  • 5Byrne SN,Limón-Flores AY,Ullrich SE.Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression[J].J Immunol,2008,180(7):4648-4655.
  • 6Grimbaldeston MA,Nakae S,Kalesnikoff J,et al.Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B[J].Nat Immunol,2007,8(10):1095-1104.
  • 7Nakae S,Suto H,Berry GJ,et al.Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice[J].Blood,2007,109(9):3640-3648.
  • 8Norman MU,Hwang J,Hulliger S,et al.Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response[J].Am J Pathol,2008,172(6):1638-1649.
  • 9Kambayashi T,Baranski JD,Baker RG,et al.Indirect involvement of allergen-captured mast cells in antigen presentation[J].Blood,2008,111(3):1489-1496.
  • 10McLachlan JB,Shelburne CP,Hart JP,et al.Mast cell activators:A new class of highly effective vaccine adjuvants[J].Nat Med,2008,14(5):536-541.

共引文献17

同被引文献156

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部